Results 261 to 270 of about 214,376 (295)

Regulation of adoptive immunotherapy.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2017
Adoptive immunotherapy using chimeric antigen receptor (CAR)-modified T cells has provided a major breakthrough in the treatment of hematological malignancies. In Japan, it is expected that CD19 CAR-T cell therapy will be introduced earlier in clinical B cell malignancy settings and/or that a novel CAR-T cell therapy will be developed for non-B cell ...
Yozo, Nakazawa, Satoshi, Suzuki, Nobuhiro, Nishio   +2 more
openaire   +1 more source

Adoptive Immunotherapy for Cancer

Scientific American, 1990
openaire   +2 more sources

Adoptive cell therapy for cancer treatment

Exploration, 2023
Yonger Xue, Yi-Zhou Dong, Shi Du
exaly  

Adoptive Cell Therapy for T-Cell Malignancies

Cancers, 2023
Jongbok Lee
exaly  

Adoptive Immunotherapy

2008
Chrystal U. Louis, Helen E. Heslop
openaire   +1 more source

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies

Cancer Cell, 2020
Douglas Palmer, Suman K Vodnala, Amanda Henning   +2 more
exaly  

ADOPTIVE IMMUNOTHERAPY

2021
KHANNA RAJIV, SINHA DEBOTTAM
openaire   +2 more sources

Adoptive Immunotherapy in Malignant Disease

Immunological Reviews, 1972
Thompson, R B, Mathe, G
openaire   +2 more sources

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

Cell Metabolism, 2018
Chantale Bernatchez, Peng Huang, Rodabe N Amaria   +2 more
exaly  

Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy

Cancer Cell, 2017
Thomas F. Gajewski, Brendan Horton, Stefani Spranger   +2 more
exaly